18.06.2021 | ASO Visual Abstract

ASO Visual Abstract: Added Value of Radiotherapy Following Neoadjuvant FOLFIRINOX for Resectable and Borderline Resectable Pancreatic Cancer—A Systematic Review and Meta-analysis

verfasst von: Quisette P. Janssen, MD, Jacob L. van Dam, MD, Isabelle G. Kivits, BSc, Marc G. Besselink, MD, PhD, Casper H. J. van Eijck, MD, PhD, Marjolein Y. V. Homs, PM, PhD, Joost J. M. E. Nuyttens, MD, PhD, Hongchao Qi, MSc, Hjalmar J. van Santvoort, MD, PhD, Alice C. Wei, MD, PhD, Roeland F. de Wilde, MD, PhD, Johanna W. Wilmink, MD, PhD, Geertjan van Tienhoven, MD, PhD, Bas Groot Koerkamp, MD

Erschienen in: Annals of Surgical Oncology | Sonderheft 3/2021